PAPER El Haj M, Gallouj K, Antoine P, Chapelet G

Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer's Disease.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Li M, Wu X, Jiang L, Liu M, Yanju G, Li X, Tian F, Ye F, Wang J, Wang S, Qin C, Zhang L

Exploring the co-morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model.

Animal Model Exp Med. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Lamisa AB, Ahammad I, Bhattacharjee A, Hossain MU, Ishtiaque A, Chowdhury ZM, Das KC, Salimullah M, Keya CA

Publisher Correction: A meta-analysis of bulk RNA-seq datasets identifies potential biomarkers and repurposable therapeutics against Alzheimer's disease.

Sci Rep. 2025 Feb 11;15(1):5135. PubMed. Corrected paper.

PAPER Meunier-Duperray L, Souchay C, Angel L, Salmon E, Bastin C

Exploring the domain specificity and the neural correlates of memory unawareness in Alzheimer's disease.

Neurobiol Aging. 2025 Apr;148:61-70. Epub 2025 Feb 5 PubMed.

PAPER Yang L, Wang Y, Shang P, Ma G

Dual-Functional Synthetic Linear and Cyclic Peptides with Anti-Amyloid and Antimicrobial Activities for Alzheimer's Disease.

Chemistry. 2025 Mar 12;31(15):e202404349. Epub 2025 Feb 19 PubMed.

PAPER Johnson JL

FKBP51 functions in regulation of circadian rhythm and Alzheimer's disease.

Cell Stress Chaperones. 2025 Feb 9; Epub 2025 Feb 9 PubMed.

PAPER Jia F, Fu L

Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer's Disease.

Mol Neurobiol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Nuovo GJ, Rice M, Zanesi N, Sawant D, Crilly C, Tili E

The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2.

Appl Immunohistochem Mol Morphol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Arafi P, Devkota S, Williams E, Maesako M, Wolfe MS

Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production.

Elife. 2025 Feb 11;13 PubMed.

PAPER Stefani A, Antelmi E, Arnaldi D, Arnulf I, During E, Högl B, Hu MM, Iranzo A, Luke R, Peever J, Postuma RB, Videnovic A, Gan-Or Z

From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease.

Mol Neurodegener. 2025 Feb 11;20(1):19. PubMed.

PAPER Furusawa-Nishii E, Solongo B, Rai K, Yoshikawa S, Chiba A, Okuzumi A, Ueno SI, Hoshino Y, Imamichi-Tatano Y, Kimura H, Hatano T, Hattori N, Miyake S

α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's disease.

J Neuroinflammation. 2025 Feb 11;22(1):38. PubMed.

PAPER Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL, Gentleman S, Alegre-Abarrategui J

Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.

Acta Neuropathol Commun. 2025 Feb 11;13(1):25. PubMed.

PAPER Simitsi AM, Sfikas E, Koros C, Papagiannakis N, Beratis I, Papadimitriou D, Antonellou R, Fragiadaki S, Kontaxopoulou D, Picillo M, Pachi I, Alefanti I, Stamelou M, Barone P, Stefanis L

Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.

J Neurol. 2025 Feb 12;272(3):203. PubMed.

PAPER Outeiro TF, Höglinger G, Lang AE, Vieira TC

Protein misfolding: understanding biology to classify and treat synucleinopathies.

J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q, Luo Y, Zhu B, Huang H, Wang J, Zhang S, Liu Z, Chen G, Luo M, Yang D

Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.

J Neurol. 2025 Feb 11;272(3):196. PubMed.